Loss of RKIP expression is associated with poor survival in GISTs.
Gastrointestinal stromal tumours (GISTs) are rare mesenchymal tumours of the digestive tract and are commonly driven by oncogenic mutations in KIT and PDGFRA genes. Tumour size, location, mitotic index and KIT/PDGFRA mutations are the most important prognostic parameters in GISTs. However, additional studies screening for new molecular prognostic markers in GISTs are missing. Raf kinase inhibitor protein (RKIP) has been considered as a suppressor of metastasis and a prognostic marker in several neoplasms. In the present study we aimed to examine whether RKIP expression is associated with GIST clinical-pathological features. Using immunohistochemistry, we determined RKIP expression levels in a well-characterised series of 70 GISTs. We found that RKIP is expressed in the great majority of cases, and absent in approximately 9% of GISTs. Additionally, we found that loss of RKIP expression was not due to the promoter methylation as assessed by methylation-specific PCR. Loss of RKIP expression was associated with poor disease-specific survival and with tumour necrosis in GISTs. Furthermore, a statistical tendency was observed between the positive RKIP expression and absence of metastasis. So far, this is the first study assessing RKIP expression levels in GISTs. We conclude that loss of RKIP expression could have an important role as prognostic marker in GISTs.
Martinho
Olga
O
Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
Gouveia
António
A
Silva
Paula
P
Pimenta
Amadeu
A
Reis
Rui Manuel
RM
Lopes
José Manuel
JM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019175:DNA Methylation; D005260:Female; D046152:Gastrointestinal Stromal Tumors / Q000737:chemistry / Q000401:mortality* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D049488:Phosphatidylethanolamine Binding Protein / Q000032:analysis / Q000235:genetics / Q000502:physiology*; D011379:Prognosis; D011401:Promoter Regions, Genetic
C511482:PEBP1 protein, human; D049488:Phosphatidylethanolamine Binding Protein
Mol Cancer Res. 2008 Jun;6(6):917-28
18567796
Mol Cell Biol. 2001 Nov;21(21):7207-17
11585904
Genes Chromosomes Cancer. 2008 Oct;47(10):853-9
18615679
J Clin Oncol. 2006 Dec 20;24(36):5672-9
17179102
Science. 2003 Jan 31;299(5607):708-10
12522257
Cancer. 2005 Feb 15;103(4):821-9
15648083
Prostate. 2006 Feb 15;66(3):248-56
16175585
Mol Cell. 2006 Aug;23(4):561-74
16916643
Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
17090188
Cell Res. 2008 Apr;18(4):452-7
18379591
Science. 1998 Jan 23;279(5350):577-80
9438854
Chem Biol. 2005 Sep;12(9):981-91
16183022
Cancer Res. 2004 Aug 1;64(15):5186-92
15289323
Oncol Rep. 2006 Sep;16(3):451-6
16865242
Int J Cancer. 2003 Oct 10;106(6):887-95
12918066
Cancer Res. 2004 Oct 1;64(19):7117-26
15466208
J Clin Oncol. 2003 Dec 1;21(23):4342-9
14645423
J Clin Oncol. 2002 Mar 15;20(6):1692-703
11896121
Acta Neuropathol. 2005 Feb;109(2):207-10
15791479
Int J Cancer. 2005 Nov 1;117(2):289-93
15900576
Gene. 1994 Mar 25;140(2):293-4
8144042
J Invest Dermatol. 2006 May;126(5):1135-42
16498399
World J Surg. 2008 Nov;32(11):2375-82
18685890
Histopathology. 2009 Jul;55(1):53-62
19614767
Int J Clin Oncol. 2007 Oct;12(5):369-74
17929119
Virchows Arch. 2007 Oct;451(4):743-9
17701051
Surgery. 2004 Sep;136(3):708-15
15349122
Nature. 2003 Dec 4;426(6966):574-9
14654844
Clin Cancer Res. 2008 Jan 1;14(1):143-8
18172264
Biochim Biophys Acta. 1984 Oct 23;790(2):174-81
6435678
J Biol Chem. 2004 Apr 23;279(17):17515-23
14766752
Biochem Pharmacol. 2004 Sep 15;68(6):1049-53
15313400
Oncogene. 2007 May 14;26(22):3279-90
17496922
Int J Surg Pathol. 2002 Apr;10(2):81-9
12075401
J Mol Evol. 1994 Dec;39(6):655-60
7807553
J Clin Pathol. 2008 Feb;61(2):203-8
17827398
Ann Surg. 2000 Jan;231(1):51-8
10636102
Am J Clin Pathol. 2007 May;127(5):820-7
17439843
Gut. 2006 Oct;55(10):1467-74
16469793
Clin Cancer Res. 2008 May 15;14(10):2994-3001
18483365
Anticancer Res. 2006 Nov-Dec;26(6B):4437-42
17201166
Mol Cell Biol. 2000 May;20(9):3079-85
10757792
J Clin Pathol. 2006 Jun;59(6):557-63
16731599
J Natl Cancer Inst. 2003 Jun 18;95(12):878-89
12813171
Clin Cancer Res. 2005 Oct 15;11(20):7392-7
16243812
Nitric Oxide. 2008 Sep;19(2):152-7
18477483
Cell Signal. 2008 Jan;20(1):1-9
17706925
J Clin Endocrinol Metab. 2008 Apr;93(4):1211-6
18230656
N Engl J Med. 2002 Aug 15;347(7):472-80
12181401
Gastroenterology. 2006 Oct;131(4):1208-17
17030190
J Clin Pathol. 2008 Apr;61(4):524-9
18375747
Annu Rev Pathol. 2008;3:557-86
18039140
Nature. 1999 Sep 9;401(6749):173-7
10490027